saccharolactone has been researched along with amoxapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awolade, P; Cele, N; Gummidi, L; Kerru, N; Oluwakemi, E; Singh, P | 1 |
| Cui, ZN; He, L; He, M; Hu, B; Li, YS; Wang, H; Wang, Q; Wang, SJ; Wei, B; Zhou, TS | 1 |
1 review(s) available for saccharolactone and amoxapine
| Article | Year |
|---|---|
Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.
Topics: Dose-Response Relationship, Drug; Glucuronidase; Glycoproteins; Humans; Molecular Structure; Structure-Activity Relationship | 2020 |
1 other study(ies) available for saccharolactone and amoxapine
| Article | Year |
|---|---|
2,5-Disubstituted furan derivatives containing 1,3,4-thiadiazole moiety as potent α-glucosidase and E. coli β-glucuronidase inhibitors.
Topics: Binding Sites; Catalytic Domain; Cell Line; Cell Survival; Escherichia coli; Escherichia coli Proteins; Furans; Glucuronidase; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship; Thiadiazoles | 2021 |